losartan has been researched along with HIV in 1 studies
Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position
HIV: Human immunodeficiency virus. A non-taxonomic and historical term referring to any of two species, specifically HIV-1 and/or HIV-2. Prior to 1986, this was called human T-lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). From 1986-1990, it was an official species called HIV. Since 1991, HIV was no longer considered an official species name; the two species were designated HIV-1 and HIV-2.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rai, P | 1 |
| Lederman, R | 1 |
| Haque, S | 1 |
| Rehman, S | 1 |
| Kumar, V | 1 |
| Sataranatrajan, K | 1 |
| Malhotra, A | 1 |
| Kasinath, BS | 1 |
| Singhal, PC | 1 |
1 other study available for losartan and HIV
| Article | Year |
|---|---|
Renin angiotensin system modulates mTOR pathway through AT2R in HIVAN.
Topics: AIDS-Associated Nephropathy; Amides; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 | 2014 |